VOLUME 13, ISSUE 3 / MARCH 2021
Editorial
MARCH 2021
Bioanalysis and the oncology revolution
- Enaksha R Wickremsinhe &
- Christopher A James
- Pages:291–294
- Published Online:4 March 2021
White Paper
JANUARY 2021
2020 White Paper on Recent Issues in Bioanalysis: BAV Guidance, CLSI H62, Biotherapeutics Stability, Parallelism Testing, CyTOF and Regulatory Feedback (Part 2A – Recommendations on Biotherapeutics Stability, PK LBA Regulated Bioanalysis, Biomarkers Assays, Cytometry Validation & Innovation Part 2B – Regulatory Agencies’ Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine)
- Susan Spitz,
- Yan Zhang,
- Sally Fischer,
- Kristina McGuire,
- Ulrike Sommer,
- Lakshmi Amaravadi,
- Abbas Bandukwala,
- Steven Eck,
- Fabio Garofolo,
- Rafiqul Islam,
- Gregor Jordan,
- Lindsay King,
- Yoshiro Saito,
- Giane Sumner,
- Linda Terry,
- Alessandra Vitaliti,
- Yow-Ming Wang,
- Christine Grimaldi,
- Alison Joyce,
- Rachel Palmer,
- … See all authors
- Pages:295–361
- Published Online:29 January 2021
Research Article
MARCH 2021
Determination and validation of aprepitant in rat plasma using LC−MS/MS
- Nazlı Erdoğar
, - Tuba Reçber ,
- Alper B İskit ,
- Erem Bilensoy ,
- Sedef Kır &
- Emirhan Nemutlu
- Pages:363–372
- Published Online:8 March 2021
Research Article
MARCH 2021
Bioanalysis of plasma acetate levels without derivatization by LC–MS/MS
- Rani J Qasem ,
- Ibrahim K Frah,
- Ahmad S Aljada &
- Faisal A Sehli
- Pages:373–386
- Published Online:4 March 2021
Research Article
MARCH 2021
Real-time PCR assay as a simple and efficient tool for viral stability study
- Bing Hu,
- Jared L Dopp,
- Gino M Salituro &
- Leonard J Rubinstein
- Pages:387–394
- Published Online:4 March 2021
Research Article
MARCH 2021
A bridging immunogenicity assay for anti-cabiralizumab antibodies: overcoming the low assay cut point and drug tolerance challenges
- Long Yuan ,
- Carol R Gleason,
- Dennis Stocker,
- Li Li,
- Jim X Shen &
- Qin C Ji
- Pages:395–407
- Published Online:4 March 2021